News

FDA includes follow-on versions in its new liposome guideline

Published on 2016/10/19

On 29 October 2015, the US Food and Drug Administration (FDA) issued a new draft guidance document for non-biological complex drugs (NBCDs). The new draft guidance on liposome drug products replaces d...

9 views

Read more →

Measures to increase generics use in Greece

Published on 2016/10/17

Austerity has forced Greece to introduce a number of measures to reduce the amount it spends on healthcare. But how have measures aimed at increasing generics use in the country been perceived by ...

25 views

Read more →

BSG guidance recommends switching to biosimilar infliximab

Published on 2016/10/14

The British Society of Gastroenterology (BSG) released new guidance in February 2016 recommending that stable patients be switched to biosimilar infliximab (CT-P13). Biosimilar infliximab...

49 views

Read more →

Consumer choice between generic and brand-name medicines in a small generics market

Published on 2016/10/12

Background Generics offer an opportunity to governments to contain pharmaceutical expenditures, as they are generally 10‒80% lower in price than the originator brand-name medicines. Belgium has...

10 views

Read more →

Differences between biosimilars and reference products

Published on 2016/10/10

A review of glycosylated biosimilars approved in the European Union (EU) and Japan has highlighted structural variances between biosimilars and their reference products [1]. Biosimilars a...

28 views

Read more →

Impact of generics on European budgets

Published on 2016/10/07

A report by the Germany-based Institute for Healthcare and Social Research (IGES) released on 16 November 2015 found that generics could contribute to reducing healthcare budgets for European coun...

17 views

Read more →

Pharmacists’ attitudes towards domestic generics in Afghanistan

Published on 2016/10/05

The aim of the study by Hassali et al. was to survey community pharmacists regarding their attitudes about the quality and price of locally manufactured medicines [1]. A cross-sectional d...

12 views

Read more →

Prescribing similar biotherapeutic products in Latin America

Published on 2016/10/03

Prescribing practices vary across different countries in Latin America and reveal gaps in understanding and in the use of distinguishable names for biologicals [1]. A 15-minute web-based ...

7 views

Read more →

Paediatric use of low-cost generic programs in the US

Published on 2016/09/30

Low-cost generic drug programs (LCGPs) in the US increase the affordability of prescription medication that can treat many common paediatric conditions. LCGPs are a loss-leader pricing strategy us...

5 views

Read more →

Generics market share in Europe

Published on 2016/09/28

Generics make a major contribution to the European drug supply, according to a report by the by Germany-based Institute for Healthcare and Social Research (IGES). In most European countri...

17 views

Read more →

Physicians’ and pharmacists’ perspectives on generics use

Published on 2016/09/26

The review study of Toverud et al. shows that both physicians and pharmacists have acknowledged strategies for generics use as an attempt to curtail increasing drug expenditures [1]. However, in N...

14 views

Read more →

Barriers to biologicals competition

Published on 2016/09/23

As finding breakthrough small-molecule drugs becomes more difficult, drug companies are increasingly turning to ‘large molecule’ biologicals. Although biologicals represent many of the most pr...

5 views

Read more →